Management of Neurogenic Diabetes Insipidus with dDAVP and Other Agents
Publisher
Springer New York
Reference86 articles.
1. Vavra I, Machova A, Holecek V, et al: Effect of a synthetic analogue of vasopressin in animals and patients with diabetes insipidus. Lancet 1: 948–952, 1968.
2. Andersson KE, Amer B: Effects of dDAVP, a synthetic analogue of vasopressin, in patients with cranial diabetes insipidus. Acta Med Scand 192: 21–27, 1972.
3. Edwards CRW, Kitau MJ, Chard T, et al: Vasopressin analogue dDAVP in diabetes insipidus: Clinical and laboratory studies. Br Med J 3: 375–378, 1973.
4. Aronson AS, Andersson KE, Bergstrand CG, et al: Treatment of diabetes insipidus in children with dDAVP, a synthetic analogue of vasopressin. Acta Paediatr Scand 62: 133–140, 1973.
5. Kauli R, Laron Z: A vasopressin analogue in treatment of diabetes insipidus. Arch Dis Child 49: 482–485, 1974.